table of content
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2022-2027)
1.4.2 East Asia Market States and Outlook (2022-2027)
1.4.3 Europe Market States and Outlook (2022-2027)
1.4.4 South Asia Market States and Outlook (2022-2027)
1.4.5 Southeast Asia Market States and Outlook (2022-2027)
1.4.6 Middle East Market States and Outlook (2022-2027)
1.4.7 Africa Market States and Outlook (2022-2027)
1.4.8 Oceania Market States and Outlook (2022-2027)
1.4.9 South America Market States and Outlook (2022-2027)
1.5 Global Pharmacokinetics Services Market Size Analysis from 2022 to 2027
1.5.1 Global Pharmacokinetics Services Market Size Analysis from 2022 to 2027 by Consumption Volume
1.5.2 Global Pharmacokinetics Services Market Size Analysis from 2022 to 2027 by Value
1.5.3 Global Pharmacokinetics Services Price Trends Analysis from 2022 to 2027
1.6 COVID-19 Outbreak: Pharmacokinetics Services Industry Impact
Chapter 2 Global Pharmacokinetics Services Competition by Types, Applications, and Top Regions and Countries
2.1 Global Pharmacokinetics Services (Volume and Value) by Type
2.1.1 Global Pharmacokinetics Services Consumption and Market Share by Type (2016-2021)
2.1.2 Global Pharmacokinetics Services Revenue and Market Share by Type (2016-2021)
2.2 Global Pharmacokinetics Services (Volume and Value) by Application
2.2.1 Global Pharmacokinetics Services Consumption and Market Share by Application (2016-2021)
2.2.2 Global Pharmacokinetics Services Revenue and Market Share by Application (2016-2021)
2.3 Global Pharmacokinetics Services (Volume and Value) by Regions
2.3.1 Global Pharmacokinetics Services Consumption and Market Share by Regions (2016-2021)
2.3.2 Global Pharmacokinetics Services Revenue and Market Share by Regions (2016-2021)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2016-2021 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2016-2021 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2016-2021 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global Pharmacokinetics Services Sales, Consumption, Export, Import by Regions (2016-2021)
4.1 Global Pharmacokinetics Services Consumption by Regions (2016-2021)
4.2 North America Pharmacokinetics Services Sales, Consumption, Export, Import (2016-2021)
4.3 East Asia Pharmacokinetics Services Sales, Consumption, Export, Import (2016-2021)
4.4 Europe Pharmacokinetics Services Sales, Consumption, Export, Import (2016-2021)
4.5 South Asia Pharmacokinetics Services Sales, Consumption, Export, Import (2016-2021)
4.6 Southeast Asia Pharmacokinetics Services Sales, Consumption, Export, Import (2016-2021)
4.7 Middle East Pharmacokinetics Services Sales, Consumption, Export, Import (2016-2021)
4.8 Africa Pharmacokinetics Services Sales, Consumption, Export, Import (2016-2021)
4.9 Oceania Pharmacokinetics Services Sales, Consumption, Export, Import (2016-2021)
4.10 South America Pharmacokinetics Services Sales, Consumption, Export, Import (2016-2021)
Chapter 5 North America Pharmacokinetics Services Market Analysis
5.1 North America Pharmacokinetics Services Consumption and Value Analysis
5.1.1 North America Pharmacokinetics Services Market Under COVID-19
5.2 North America Pharmacokinetics Services Consumption Volume by Types
5.3 North America Pharmacokinetics Services Consumption Structure by Application
5.4 North America Pharmacokinetics Services Consumption by Top Countries
5.4.1 United States Pharmacokinetics Services Consumption Volume from 2016 to 2021
5.4.2 Canada Pharmacokinetics Services Consumption Volume from 2016 to 2021
5.4.3 Mexico Pharmacokinetics Services Consumption Volume from 2016 to 2021
Chapter 6 East Asia Pharmacokinetics Services Market Analysis
6.1 East Asia Pharmacokinetics Services Consumption and Value Analysis
6.1.1 East Asia Pharmacokinetics Services Market Under COVID-19
6.2 East Asia Pharmacokinetics Services Consumption Volume by Types
6.3 East Asia Pharmacokinetics Services Consumption Structure by Application
6.4 East Asia Pharmacokinetics Services Consumption by Top Countries
6.4.1 China Pharmacokinetics Services Consumption Volume from 2016 to 2021
6.4.2 Japan Pharmacokinetics Services Consumption Volume from 2016 to 2021
6.4.3 South Korea Pharmacokinetics Services Consumption Volume from 2016 to 2021
Chapter 7 Europe Pharmacokinetics Services Market Analysis
7.1 Europe Pharmacokinetics Services Consumption and Value Analysis
7.1.1 Europe Pharmacokinetics Services Market Under COVID-19
7.2 Europe Pharmacokinetics Services Consumption Volume by Types
7.3 Europe Pharmacokinetics Services Consumption Structure by Application
7.4 Europe Pharmacokinetics Services Consumption by Top Countries
7.4.1 Germany Pharmacokinetics Services Consumption Volume from 2016 to 2021
7.4.2 UK Pharmacokinetics Services Consumption Volume from 2016 to 2021
7.4.3 France Pharmacokinetics Services Consumption Volume from 2016 to 2021
7.4.4 Italy Pharmacokinetics Services Consumption Volume from 2016 to 2021
7.4.5 Russia Pharmacokinetics Services Consumption Volume from 2016 to 2021
7.4.6 Spain Pharmacokinetics Services Consumption Volume from 2016 to 2021
7.4.7 Netherlands Pharmacokinetics Services Consumption Volume from 2016 to 2021
7.4.8 Switzerland Pharmacokinetics Services Consumption Volume from 2016 to 2021
7.4.9 Poland Pharmacokinetics Services Consumption Volume from 2016 to 2021
Chapter 8 South Asia Pharmacokinetics Services Market Analysis
8.1 South Asia Pharmacokinetics Services Consumption and Value Analysis
8.1.1 South Asia Pharmacokinetics Services Market Under COVID-19
8.2 South Asia Pharmacokinetics Services Consumption Volume by Types
8.3 South Asia Pharmacokinetics Services Consumption Structure by Application
8.4 South Asia Pharmacokinetics Services Consumption by Top Countries
8.4.1 India Pharmacokinetics Services Consumption Volume from 2016 to 2021
8.4.2 Pakistan Pharmacokinetics Services Consumption Volume from 2016 to 2021
8.4.3 Bangladesh Pharmacokinetics Services Consumption Volume from 2016 to 2021
Chapter 9 Southeast Asia Pharmacokinetics Services Market Analysis
9.1 Southeast Asia Pharmacokinetics Services Consumption and Value Analysis
9.1.1 Southeast Asia Pharmacokinetics Services Market Under COVID-19
9.2 Southeast Asia Pharmacokinetics Services Consumption Volume by Types
9.3 Southeast Asia Pharmacokinetics Services Consumption Structure by Application
9.4 Southeast Asia Pharmacokinetics Services Consumption by Top Countries
9.4.1 Indonesia Pharmacokinetics Services Consumption Volume from 2016 to 2021
9.4.2 Thailand Pharmacokinetics Services Consumption Volume from 2016 to 2021
9.4.3 Singapore Pharmacokinetics Services Consumption Volume from 2016 to 2021
9.4.4 Malaysia Pharmacokinetics Services Consumption Volume from 2016 to 2021
9.4.5 Philippines Pharmacokinetics Services Consumption Volume from 2016 to 2021
9.4.6 Vietnam Pharmacokinetics Services Consumption Volume from 2016 to 2021
9.4.7 Myanmar Pharmacokinetics Services Consumption Volume from 2016 to 2021
Chapter 10 Middle East Pharmacokinetics Services Market Analysis
10.1 Middle East Pharmacokinetics Services Consumption and Value Analysis
10.1.1 Middle East Pharmacokinetics Services Market Under COVID-19
10.2 Middle East Pharmacokinetics Services Consumption Volume by Types
10.3 Middle East Pharmacokinetics Services Consumption Structure by Application
10.4 Middle East Pharmacokinetics Services Consumption by Top Countries
10.4.1 Turkey Pharmacokinetics Services Consumption Volume from 2016 to 2021
10.4.2 Saudi Arabia Pharmacokinetics Services Consumption Volume from 2016 to 2021
10.4.3 Iran Pharmacokinetics Services Consumption Volume from 2016 to 2021
10.4.4 United Arab Emirates Pharmacokinetics Services Consumption Volume from 2016 to 2021
10.4.5 Israel Pharmacokinetics Services Consumption Volume from 2016 to 2021
10.4.6 Iraq Pharmacokinetics Services Consumption Volume from 2016 to 2021
10.4.7 Qatar Pharmacokinetics Services Consumption Volume from 2016 to 2021
10.4.8 Kuwait Pharmacokinetics Services Consumption Volume from 2016 to 2021
10.4.9 Oman Pharmacokinetics Services Consumption Volume from 2016 to 2021
Chapter 11 Africa Pharmacokinetics Services Market Analysis
11.1 Africa Pharmacokinetics Services Consumption and Value Analysis
11.1.1 Africa Pharmacokinetics Services Market Under COVID-19
11.2 Africa Pharmacokinetics Services Consumption Volume by Types
11.3 Africa Pharmacokinetics Services Consumption Structure by Application
11.4 Africa Pharmacokinetics Services Consumption by Top Countries
11.4.1 Nigeria Pharmacokinetics Services Consumption Volume from 2016 to 2021
11.4.2 South Africa Pharmacokinetics Services Consumption Volume from 2016 to 2021
11.4.3 Egypt Pharmacokinetics Services Consumption Volume from 2016 to 2021
11.4.4 Algeria Pharmacokinetics Services Consumption Volume from 2016 to 2021
11.4.5 Morocco Pharmacokinetics Services Consumption Volume from 2016 to 2021
Chapter 12 Oceania Pharmacokinetics Services Market Analysis
12.1 Oceania Pharmacokinetics Services Consumption and Value Analysis
12.2 Oceania Pharmacokinetics Services Consumption Volume by Types
12.3 Oceania Pharmacokinetics Services Consumption Structure by Application
12.4 Oceania Pharmacokinetics Services Consumption by Top Countries
12.4.1 Australia Pharmacokinetics Services Consumption Volume from 2016 to 2021
12.4.2 New Zealand Pharmacokinetics Services Consumption Volume from 2016 to 2021
Chapter 13 South America Pharmacokinetics Services Market Analysis
13.1 South America Pharmacokinetics Services Consumption and Value Analysis
13.1.1 South America Pharmacokinetics Services Market Under COVID-19
13.2 South America Pharmacokinetics Services Consumption Volume by Types
13.3 South America Pharmacokinetics Services Consumption Structure by Application
13.4 South America Pharmacokinetics Services Consumption Volume by Major Countries
13.4.1 Brazil Pharmacokinetics Services Consumption Volume from 2016 to 2021
13.4.2 Argentina Pharmacokinetics Services Consumption Volume from 2016 to 2021
13.4.3 Columbia Pharmacokinetics Services Consumption Volume from 2016 to 2021
13.4.4 Chile Pharmacokinetics Services Consumption Volume from 2016 to 2021
13.4.5 Venezuela Pharmacokinetics Services Consumption Volume from 2016 to 2021
13.4.6 Peru Pharmacokinetics Services Consumption Volume from 2016 to 2021
13.4.7 Puerto Rico Pharmacokinetics Services Consumption Volume from 2016 to 2021
13.4.8 Ecuador Pharmacokinetics Services Consumption Volume from 2016 to 2021
Chapter 14 Company Profiles and Key Figures in Pharmacokinetics Services Business
14.1 Evotec AG (Germany)
14.1.1 Evotec AG (Germany) Company Profile
14.1.2 Evotec AG (Germany) Pharmacokinetics Services Product Specification
14.1.3 Evotec AG (Germany) Pharmacokinetics Services Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.2 Pacific BioLabs (US)
14.2.1 Pacific BioLabs (US) Company Profile
14.2.2 Pacific BioLabs (US) Pharmacokinetics Services Product Specification
14.2.3 Pacific BioLabs (US) Pharmacokinetics Services Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.3 GVK Biosciences Private Limited (India)
14.3.1 GVK Biosciences Private Limited (India) Company Profile
14.3.2 GVK Biosciences Private Limited (India) Pharmacokinetics Services Product Specification
14.3.3 GVK Biosciences Private Limited (India) Pharmacokinetics Services Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.4 Shanghai Medicilon Inc. (China)
14.4.1 Shanghai Medicilon Inc. (China) Company Profile
14.4.2 Shanghai Medicilon Inc. (China) Pharmacokinetics Services Product Specification
14.4.3 Shanghai Medicilon Inc. (China) Pharmacokinetics Services Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.5 Pharmaceutical Product Development, LLC (US)
14.5.1 Pharmaceutical Product Development, LLC (US) Company Profile
14.5.2 Pharmaceutical Product Development, LLC (US) Pharmacokinetics Services Product Specification
14.5.3 Pharmaceutical Product Development, LLC (US) Pharmacokinetics Services Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.6 Charles River Laboratories International, Inc. (US)
14.6.1 Charles River Laboratories International, Inc. (US) Company Profile
14.6.2 Charles River Laboratories International, Inc. (US) Pharmacokinetics Services Product Specification
14.6.3 Charles River Laboratories International, Inc. (US) Pharmacokinetics Services Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.7 PAREXEL International Corporation (US)
14.7.1 PAREXEL International Corporation (US) Company Profile
14.7.2 PAREXEL International Corporation (US) Pharmacokinetics Services Product Specification
14.7.3 PAREXEL International Corporation (US) Pharmacokinetics Services Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.8 Eurofins Scientific, Inc. (Luxembourg)
14.8.1 Eurofins Scientific, Inc. (Luxembourg) Company Profile
14.8.2 Eurofins Scientific, Inc. (Luxembourg) Pharmacokinetics Services Product Specification
14.8.3 Eurofins Scientific, Inc. (Luxembourg) Pharmacokinetics Services Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.9 Frontage Labs (US)
14.9.1 Frontage Labs (US) Company Profile
14.9.2 Frontage Labs (US) Pharmacokinetics Services Product Specification
14.9.3 Frontage Labs (US) Pharmacokinetics Services Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.10 SGS SA (Switzerland)
14.10.1 SGS SA (Switzerland) Company Profile
14.10.2 SGS SA (Switzerland) Pharmacokinetics Services Product Specification
14.10.3 SGS SA (Switzerland) Pharmacokinetics Services Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.11 LGC Limited (UK)
14.11.1 LGC Limited (UK) Company Profile
14.11.2 LGC Limited (UK) Pharmacokinetics Services Product Specification
14.11.3 LGC Limited (UK) Pharmacokinetics Services Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.12 Creative Bioarray (US)
14.12.1 Creative Bioarray (US) Company Profile
14.12.2 Creative Bioarray (US) Pharmacokinetics Services Product Specification
14.12.3 Creative Bioarray (US) Pharmacokinetics Services Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.13 Certara, L.P. (Germany)
14.13.1 Certara, L.P. (Germany) Company Profile
14.13.2 Certara, L.P. (Germany) Pharmacokinetics Services Product Specification
14.13.3 Certara, L.P. (Germany) Pharmacokinetics Services Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Chapter 15 Global Pharmacokinetics Services Market Forecast (2022-2027)
15.1 Global Pharmacokinetics Services Consumption Volume, Revenue and Price Forecast (2022-2027)
15.1.1 Global Pharmacokinetics Services Consumption Volume and Growth Rate Forecast (2022-2027)
15.1.2 Global Pharmacokinetics Services Value and Growth Rate Forecast (2022-2027)
15.2 Global Pharmacokinetics Services Consumption Volume, Value and Growth Rate Forecast by Region (2022-2027)
15.2.1 Global Pharmacokinetics Services Consumption Volume and Growth Rate Forecast by Regions (2022-2027)
15.2.2 Global Pharmacokinetics Services Value and Growth Rate Forecast by Regions (2022-2027)
15.2.3 North America Pharmacokinetics Services Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.4 East Asia Pharmacokinetics Services Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.5 Europe Pharmacokinetics Services Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.6 South Asia Pharmacokinetics Services Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.7 Southeast Asia Pharmacokinetics Services Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.8 Middle East Pharmacokinetics Services Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.9 Africa Pharmacokinetics Services Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.10 Oceania Pharmacokinetics Services Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.11 South America Pharmacokinetics Services Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.3 Global Pharmacokinetics Services Consumption Volume, Revenue and Price Forecast by Type (2022-2027)
15.3.1 Global Pharmacokinetics Services Consumption Forecast by Type (2022-2027)
15.3.2 Global Pharmacokinetics Services Revenue Forecast by Type (2022-2027)
15.3.3 Global Pharmacokinetics Services Price Forecast by Type (2022-2027)
15.4 Global Pharmacokinetics Services Consumption Volume Forecast by Application (2022-2027)
15.5 Pharmacokinetics Services Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology
